Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
Relmada reconsiders plans to test psilocybin for obesity
Relmada’s attempts to see whether a magic mushroom extract could be used to treat obesity may be coming to an end before they really began.
James Waldron
Mar 28, 2025 10:00am
Novo pens $2B deal for triple agonist weight loss drug
Mar 24, 2025 9:50am
'Not a cost-cutting exercise': Novo Nordisk reshapes R&D setup
Mar 20, 2025 10:15am
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Mar 17, 2025 10:10am
Harbour launches obesity biotech on mission to preserve muscle
Mar 12, 2025 8:15am
Amgen’s late-stage obesity trials expected to read out in ‘27
Mar 5, 2025 1:58pm
